Gene Therapy Technologies, Applications and Regulations -

Gene Therapy Technologies, Applications and Regulations

From Laboratory to Clinic

Anthony Meager (Herausgeber)

Buch | Hardcover
400 Seiten
1999
John Wiley & Sons Inc (Verlag)
978-0-471-96709-5 (ISBN)
335,93 inkl. MwSt
Considered an extremely promising area of biomedical research, gene therapy has the potential to treat diseases both inherited and acquired (e.g. , cystic fibrosis and cancer), and may eventually complement or replace conventional drug therapy.
Gene Therapy Technologies, Applications and Regulations From Laboratory to Clinic Edited by Anthony Meager Division of Immunobiology, The National Institute for Biological Standards and Control, South Mimms, UK The development of gene-based technologies has been rapid over the past decade and has consequently resulted in a surge of interest in human gene therapy, the deliberate transfer of genes to somatic cells to cure or alleviate disease symptoms. Hundreds of clinical protocols involving variously designed vectors for efficient gene transfer have been developed. However, the use of such complex 'gene medicines' containing potentially heritable genes has raised numerous concerns regarding quality, efficacy and safety. Encompassing recent developments in the field and addressing current concerns this book:
* surveys many of the current technologies for preparing vectors for use in gene therapy protocols
* reviews the application of gene-mediated therapies to a range of medical conditions
* considers the regulatory aspects of gene therapy including product quality and safety requirements
* appraises the transfer of technologies from laboratory to clinic with regard to the attendant requirements and facilities for:
* good laboratory practice (GLP) conditions in the R&D laboratory
* large-scale production methods and good manufacturing practice (GMP)
* current in-process and final product testing

Written by international experts knowledgeable about many aspects of human somatic gene therapy, this book will be an essential guide for those embarking on gene therapy technologies relevant to specifications of production and testing of products (and procedures) required to meet existing regulations, including quality, efficacy and safety considerations.

Anthony Meager is a Principal Scientist in the Division of Immunology and Endocrinology, The National Institute for Biological Standards and Control, UK. Following his PhD in Biochemistry, he has carried out research in biochemistry, cell biology, immunology, virology, and cytokines, especially interferons and tumor necrosis factor. He joined the NIBSC in 1980. Currently, he heads laboratories involved in the biological standardization of IFN and TNF, and research studies on the bioactivity and immunogenicity of cytokines. From 1990, he has also contributed to regulatory guidance on gene therapy, both for the European Medicines Agency and the World Health Organization.

Cationic Liposomes for Gene Therapy Applications (J. Clancy & E. Sorscher).

DNA Condensation and Receptor-mediated Gene Transfer (A. Ziady & T. Ferkol).

Retroviral Vectors (W. Günzburg & B. Salmons).

Lentiviral Vectors (A. Lever).

Adenoviral Vectors (S. Connelly).

Adeno-associated Viral Vectors (T. Flotte & B. Carter).

Advances in Engineering HSV Vectors for Gene Transfer to the Nervous System (M. Soares, et al.).

Mammalian Artificial Chromosomes: Prospects for Gene Therapy (T. Ebersole & C. Farr).

Gene Therapy for Severe Combined Immunodeficiency (A. Thrasher, et al.).

Gene Therapy for Haemophilia (R. Hoeben, et al.).

Cystic Fibrosis: Gene Therapy Approaches (N. Caplen).

Therapeutic Approaches to Haemoglobinopathies (Y. Beuzard).

Gene Therapy Approaches to Duchenne Muscular Dystrophy (S. Murphy & G. Dickson).

Lysosomal Storage Diseases (L. Lashford, et al.).

Prospects for Gene Therapy of HIV Infections and AIDS (C. Lee, et al.).

The Developemnt of the Regulatory Process in Europe for Biological Medicines: How it Affects Gene Therapy Products (A. Meager, et al.).

Developement and Regulation of Gene Therapy Drugs in Germany (K. Cichutek).

The Transfer of Technology from the Laboratory to the Clinic: In Process Controls and Final Product Testing (F. Borellini & J. Ostrove).

Good Laboratory Practice in the Research and Development Laboratory (A. Shepherd).

Facilities for Large-scale Production of Vectors Under GMP Conditions (J. Boyd).

Addendum.

Index.

Erscheint lt. Verlag 29.10.1999
Verlagsort New York
Sprache englisch
Maße 159 x 236 mm
Gewicht 737 g
Einbandart gebunden
Themenwelt Studium 2. Studienabschnitt (Klinik) Humangenetik
Naturwissenschaften Biologie Genetik / Molekularbiologie
Recht / Steuern Arbeits- / Sozialrecht Sozialrecht
Recht / Steuern EU / Internationales Recht
ISBN-10 0-471-96709-2 / 0471967092
ISBN-13 978-0-471-96709-5 / 9780471967095
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
Eine sehr persönliche Geschichte | Der New York Times-Bestseller

von Siddhartha Mukherjee

Buch | Softcover (2023)
Ullstein Taschenbuch Verlag
21,99
Die revolutionäre Medizin von morgen (Lifespan)

von David A. Sinclair; Matthew D. LaPlante

Buch | Softcover (2020)
DuMont Buchverlag
16,00